{"disease":{"id":"fatty-acid-oxidation-disorder","name":"fatty acid oxidation disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04482049","title":"A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Reneo Pharma Ltd","has_results":false},{"nct_id":"NCT05924555","title":"Exercise Intolerance Study in Long Chain Fatty Acid Oxidation Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT01886378","title":"A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":true},{"nct_id":"NCT03833128","title":"A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Reneo Pharma Ltd","has_results":false},{"nct_id":"NCT03768817","title":"Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access Program","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":false},{"nct_id":"NCT04309214","title":"Market Research - Acceptability Study for New MCT Fat Products","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Dr. Schär AG / SPA","has_results":false},{"nct_id":"NCT04309149","title":"Market Research - Acceptability Study for a Range of MCT Products","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Dr. Schär AG / SPA","has_results":false},{"nct_id":"NCT04009642","title":"Cardiac Rest and Stress Metabolism in Patients With Type 2 Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"University of Leicester","has_results":false},{"nct_id":"NCT04812106","title":"Long-Chain Fatty Acid Oxidation Disorders Online Disease Monitoring Program","phase":"","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":false},{"nct_id":"NCT04400422","title":"Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Dr. Schär AG / SPA","has_results":false},{"nct_id":"NCT03773770","title":"Expanded Access to Triheptanoin","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}